Tremelimumab (anti-CTLA-4)

Ask supplier a question | View on supplier's website

Tremelimumab (Ticilimumab, CP-675,206) is a fully human monoclonal antibody that binds to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) on the surface of activated T lymphocytes.

Supplier	Selleck Chemicals
Product #	A2021
Sku #	A2021-1mg*5
Pricing	1mg*5, $717.00

Feedback